Literature DB >> 9097259

Fractures after myelopathy: the risk quantified.

J H Frisbie1.   

Abstract

Fractures of the lower extremities have been recognized as a complication of paralysis with myelopathy due to spinal cord injury and impairment (SCI), but the risk has not been quantified and the effect of age, a correlate of predisposing osteoporosis, has not been documented. A long term follow-up review of patients with SCI was conducted to answer these questions. One hundred twenty male SCI patients (91 percent traumatic) were reviewed; the duration of paralysis at follow-up was 21.1 +/- 12.1 years. Forty patients (33 percent) had sustained 76 fracture events resulting in 103 fractures (82 percent in the long bones of the lower extremities). The incidence of fracture events was directly related to age (14.5, 31.1 and 45.7 events per 1000 patient years for age intervals of 20 to 39, 40 to 59 and 60 to 79 years, respectively). Incidence rates for femoral (including hip) fracture in SCI patients were greater than those for the general population of men by factors of 104 and 24 at ages 50 and 70, respectively. In conclusion, the risk of fracture of lower extremity long bones in men is markedly increased by myelopathy and is raised further with aging.

Entities:  

Mesh:

Year:  1997        PMID: 9097259     DOI: 10.1080/10790268.1997.11719458

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  19 in total

Review 1.  Bone Imaging and Fracture Risk after Spinal Cord Injury.

Authors:  W Brent Edwards; Thomas J Schnitzer
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

2.  Physiatrists' opinions and practice patterns for bone health after SCI.

Authors:  M C Ashe; J J Eng; A Krassioukov
Journal:  Spinal Cord       Date:  2008-08-19       Impact factor: 2.772

Review 3.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

4.  Evidence-based prevention and treatment of osteoporosis after spinal cord injury: a systematic review.

Authors:  Saeed Soleyman-Jahi; Ali Yousefian; Radin Maheronnaghsh; Farhad Shokraneh; Shayan Abdollah Zadegan; Akbar Soltani; Seyed Mostafa Hosseini; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  Eur Spine J       Date:  2017-05-11       Impact factor: 3.134

5.  Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.

Authors:  M Bethel; F M Weaver; L Bailey; S Miskevics; J N Svircev; S P Burns; H Hoenig; K Lyles; L D Carbone
Journal:  Osteoporos Int       Date:  2016-05-26       Impact factor: 4.507

6.  Bone changes in the lower limbs from participation in an FES rowing exercise program implemented within two years after traumatic spinal cord injury.

Authors:  Rebecca L Lambach; Nicole E Stafford; Julie A Kolesar; B Jenny Kiratli; Graham H Creasey; Robin S Gibbons; Brian J Andrews; Gary S Beaupre
Journal:  J Spinal Cord Med       Date:  2018-11-26       Impact factor: 1.985

7.  Trabecular bone is more deteriorated in spinal cord injured versus estrogen-free postmenopausal women.

Authors:  Jill M Slade; C Scott Bickel; Christopher M Modlesky; Sharmila Majumdar; Gary A Dudley
Journal:  Osteoporos Int       Date:  2004-08-28       Impact factor: 4.507

8.  The mechanical consequence of actual bone loss and simulated bone recovery in acute spinal cord injury.

Authors:  W Brent Edwards; Thomas J Schnitzer; Karen L Troy
Journal:  Bone       Date:  2013-12-17       Impact factor: 4.398

9.  Femoral loads during passive, active, and active-resistive stance after spinal cord injury: a mathematical model.

Authors:  Laura A Frey Law; Richard K Shields
Journal:  Clin Biomech (Bristol, Avon)       Date:  2004-03       Impact factor: 2.063

10.  Morbidity following lower extremity fractures in men with spinal cord injury.

Authors:  L D Carbone; A S Chin; S P Burns; J N Svircev; H Hoenig; M Heggeness; F Weaver
Journal:  Osteoporos Int       Date:  2013-02-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.